Delivery Order SPE2DB22D3301-SPE2DB25FX5JN
Award Date
11/12/24
Potential Completion Date
11/13/24
Potential Value
$6.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,156.39 firm fixed-price delivery order is for the supply of ZORYVE 0.3% CREAM 60GM, a pharmaceutical product. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Zoryve 0.3% cream in a 60 gram package. The $1,084.84 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 21, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $2,012.77, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564362240 ZORYVE 0.3% Cream 60GM, a pharmaceutical product, over a period ending on April 23, 2024. Amerisourcebergen Drug Corp, a subsidiary of the large pharmaceutical distribution company Amerisourcebergen Corporation, holds a significant Indefinite Delivery...
This federal contract award, with the ID SPE2DX15D3020|SPE2DX25FPXTM, was granted to AmerisourceBergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,461.96 firm fixed-price delivery order is for the supply of the pharmaceutical product ZORYVE 0.3% Cream, 60GM. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the agency to...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $4,026.25 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Zoryve 0.3% cream in 60 gram quantities. This delivery order has a completion date of February 12, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, holds an indefinite delivery contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $6,306.68 delivery order contract is for the supply of ZORYVE 0.3% foam, a pharmaceutical product, with an ultimate completion date of October 11, 2024. This contract is not set aside for any specific business category. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has been awarded numerous federal contracts and...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,456.07 fixed-price delivery order is for ZORYVE 0.3% FOAM 60GM and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The contract is for the supply of a pharmaceutical product, ZORYVE 0.3% cream, and has a ceiling value of $3,090.84. The contract is not associated with a set-aside designation. It is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $97,663.02 firm fixed-price delivery order contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, with ID SPE2DB22D1106|SPE2DB25FDSR8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,897.25 firm fixed-price delivery order is for ZORYVE 0.3% FOAM 60GM, a medical product. The contract has an ultimate completion date of January 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...